PTCT

PTC Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

[PR Newswire] – SOUTH PLAINFIELD, N.J., Feb. 27, 2014 /PRNewswire/ — PTC Therapeutics, Inc. (PTCT) today announced that it granted a non-statutory stock option to purchase 150,000 shares of its common stock to Robert Spiegel, M.D., PTC’s newly appointed moreView todays social media effects on PTCTView the latest stocks trending across Twitter. Click to view dashboardSee who PTC is hiring […]

PTC Therapeutics to Host Fourth Quarter and Year End 2013 Financial Results Conference Call

[PR Newswire] – SOUTH PLAINFIELD, N.J., Feb. 27, 2014 /PRNewswire/ — PTC Therapeutics, Inc. (PTCT) today announced that will host a webcast conference call to discuss financial results for the fourth quarter and year end 2013 on Thursday, March 6, 2014 moreView todays social media effects on PTCTView the latest stocks trending across Twitter. Click to view dashboardSee who […]

PTC Therapeutics Expands International Commercial Team

[PR Newswire] – SOUTH PLAINFIELD, N.J., Feb. 25, 2014 /PRNewswire/ — PTC Therapeutics, Inc. (PTCT) today announced the appointment of Guido Schopen, M.D. to General Manager and Head of Medical Affairs for Europe. Dr. Schopen will be responsible for Euro moreView todays social media effects on PTCTView the latest stocks trending across Twitter. Click to view dashboardSee who PTC is […]

PTC Therapeutics to Present at Upcoming Investor Conferences

[PR Newswire] – SOUTH PLAINFIELD, N.J., Feb. 20, 2014 /PRNewswire/ — PTC Therapeutics, Inc. (PTCT) today announced that they will participate in two upcoming investor conferences: – Management will participate in a panel entitled DMD Back in the Spotlig moreView todays social media effects on PTCTView the latest stocks trending across Twitter. Click to view dashboardSee who PTC is hiring […]

PTC Therapeutics Announces Closing of Registered Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

[PR Newswire] – SOUTH PLAINFIELD, N.J., Feb. 19, 2014 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the closing of its previously announced registered public offering of 5,163,265 shares of its … moreView todays social media effects on PTCTView the latest stocks trending across Twitter. Click to view dashboardSee who PTC is hiring next, click here to view […]